Organon & Co. (BMV:OGN)
133.00
-2.00 (-1.48%)
At close: Dec 3, 2025
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2019 - 2020 |
| Women's Health Revenue | 1.82B | 1.78B |
Log In |
Log In |
Log In | Upgrade
|
| Biosimilars Revenue | 673.00M | 662.00M |
Log In |
Log In |
Log In | Upgrade
|
| Established Brands Revenue | 3.71B | 3.85B |
Log In |
Log In |
Log In | Upgrade
|
| Other Product Group Revenue | 94.00M | 115.00M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 6.30B | 6.40B |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2019 - 2020 |
| United States Revenue | 1.65B | 1.57B |
Log In |
Log In |
Log In | Upgrade
|
| Europe and Canada Revenue | 1.63B | 1.76B |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific and Japan Revenue | 996.00M | 1.05B |
Log In |
Log In |
Log In | Upgrade
|
| China Revenue | 840.00M | 847.00M |
Log In |
Log In |
Log In | Upgrade
|
| Latin America, Middle East, Russia and Africa Revenue | 1.08B | 1.03B |
Log In |
Log In |
Log In | Upgrade
|
| Other International Revenue | 108.00M | 137.00M |
Log In |
Log In |
Log In | Upgrade
|
| International Revenue | 4.65B | 4.83B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 6.30B | 6.40B |
Log In |
Log In |
Log In | Upgrade
|